Patents by Inventor Eun Sil Yu

Eun Sil Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130023442
    Abstract: Single nucleotide polymorphisms (SNP) for predicting recurrence of hepatocellular carcinoma after curative surgical resection are provided. The SNPs have a significant correlation with higher risk of hepatocellular carcinoma recurrence after curative surgical resection. Therefore, the SNPs can be used in developing micro-arrays or test kits for predicting recurrence of hepatocellular carcinoma, and in screening drugs to prevent recurrence of hepatocellular carcinoma after curative surgical resection.
    Type: Application
    Filed: March 22, 2011
    Publication date: January 24, 2013
    Inventors: Young Hwa Chung, Eun Sil Yu, Young-Joo Lee, Jeong A. Kim, Jong-Eun Lee
  • Publication number: 20130017975
    Abstract: Single nucleotide polymorphisms (SNP) for predicting prognosis of hepatocellular carcinoma after curative surgical resection are provided. The SNPs have a significant correlation with an over-expression of MTA1 which is useful prognostic factor for prediction of prognosis or poor survival after curative surgical resection of hepatocellular carcinoma. Therefore, the SNPs can be used in developing micro-arrays or test kits for prediction of the prognosis of hepatocellular carcinoma, and in screening drugs to improve poor prognosis of hepatocellular carcinoma after curative surgical resection.
    Type: Application
    Filed: March 22, 2011
    Publication date: January 17, 2013
    Applicant: University of Ulsan Foundation For Industry Cooperation
    Inventors: Young Hwa Chung, Neung Hwa Park, Eun Sil Yu, Young-Joo Lee, Jeong A Kim, Dan-Bi Lee, Sae-Hwan Lee, Jong-Eun Lee
  • Publication number: 20110171661
    Abstract: Provided are a method of diagnosing the recurrence or possibility of recurrence of hepatocellular carcinoma after hepatocellular carcinoma surgery and a method of screening a drug for preventing the recurrence of hepatocellular carcinoma after hepatocellular carcinoma surgery and treating hepatocellular carcinoma. Specifically, the recurrence or possibility of recurrence of hepatocellular carcinoma after hepatocellular carcinoma surgery is diagnosed and a drug for preventing the recurrence of hepatocellular carcinoma after surgery and treating hepatocellular carcinoma is screened, by measuring expression levels of a metastatic tumor antigen 1 or metastasis associated 1 (MTA1) protein in a biological sample taken from a patient in which hepatocellular carcinoma recurs or is likely to recur after hepatocellular carcinoma surgery and comparing the measured expression levels of the MTA1 protein with those of a normal control group.
    Type: Application
    Filed: August 26, 2008
    Publication date: July 14, 2011
    Inventors: Young Hwa Chung, Eun Sil Yu, Soo Hyung Ryu, Kyu Won Kim, Jeong A Kim